| Frontotemporal dementia: clinical, neuroimaging, and molecular biological findings in 6 patients. | |
| | |
MedLine Citation:
|
PMID: 11829209 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Establishing the diagnosis in patients with clinical signs and symptoms suggesting primary degenerative disease with marked frontal lobe involvement is difficult. Neuroimaging methods, in particular positron emission tomography (PET) with the tracer 18fluoro-2-deoxyglucose (FDG) and cerebrospinal fluid (CSF) examination of beta-amyloid and tau-protein levels may give additional information. We report five patients with clinical and radiological features of degenerative dementia with predominantly frontal involvement and one patient with primary progressive aphasia Diagnostic work-up included computed tomography (CT), magnetic resonance imaging (MRI), PET and tau-protein and beta-amyloid level determination in CSF. While neuropsychological performance varied among patients, CT and MRI demonstrated persistently frontal lobe involvement. PET revealed corresponding changes with frontal hypometabolism, but in addition, four patients (among them two with no corresponding temporal changes in CT or MRI) showed a decreased glucose uptake in the temporal cortices. CSF samples from five patients revealed elevated beta-amyloid 1-42 and tau levels in three and two patients, respectively. Reduced beta-amyloid 1-40 was found in two patients. We conclude that occurrence of clinical symptoms of frontotemporal dementia is accompanied by frontal hypometabolism regardless of additional clinical findings. The value of determination of beta-amyloid and tau protein levels remains to be determined. |
| | |
Authors:
|
M Jauss; K Herholz; L Kracht; J Pantel; T Hartmann; M Jensen; M Essig; J Schröder |
Related Documents
:
|
16873009 - The role of conventional mr and ct in the work-up of dementia patients. 16990669 - Quantitative mr imaging in alzheimer disease. 2105589 - Ct diagnostic features of alzheimer disease: importance of the choroidal/hippocampal fi... 20443979 - A novel mri-biomarker candidate for alzheimer's disease composed of regional brain volu... 6446279 - Decreased computerized tomography numbers in patients with presenile dementia. detectio... 18846369 - Support vector machine-based classification of alzheimer's disease from whole-brain ana... 16601479 - Current applications of fetal cardiac imaging technology. 23026229 - Multiple small hyperintense lesions in the subcortical white matter on cranial mr image... 1627449 - Ultrafast computed tomography of the heart. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: European archives of psychiatry and clinical neuroscience Volume: 251 ISSN: 0940-1334 ISO Abbreviation: Eur Arch Psychiatry Clin Neurosci Publication Date: 2001 Oct |
Date Detail:
|
Created Date: 2002-02-06 Completed Date: 2002-07-09 Revised Date: 2009-05-11 |
Medline Journal Info:
|
Nlm Unique ID: 9103030 Medline TA: Eur Arch Psychiatry Clin Neurosci Country: Germany |
Other Details:
|
Languages: eng Pagination: 225-31 Citation Subset: IM |
Affiliation:
|
Dept of Neurology, University of Giessen, Germany. marek.jauss@neuro.med.uni-giessen.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Amyloid beta-Protein / cerebrospinal fluid, metabolism Cerebrospinal Fluid Proteins / metabolism Dementia / metabolism, pathology*, psychology* Female Frontal Lobe / metabolism*, pathology* Humans Individuality Magnetic Resonance Imaging Male Middle Aged Peptide Fragments / cerebrospinal fluid, metabolism Psychiatric Status Rating Scales Temporal Lobe / metabolism*, pathology* Tomography, Emission-Computed Tomography, X-Ray Computed tau Proteins / cerebrospinal fluid, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Amyloid beta-Protein; 0/Cerebrospinal Fluid Proteins; 0/Peptide Fragments; 0/amyloid beta-protein (1-40); 0/tau Proteins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Amisulpride: efficacy in the management of chronic patients with predominant negative symptoms of sc...
Next Document: Psychopathology in dual diagnosis and non-addicted schizophrenics--are there differences?